Halozyme Therapeutics
HALO
#2488
Rank
C$8.11 B
Marketcap
$63.80
Share price
-0.13%
Change (1 day)
16.20%
Change (1 year)

Halozyme Therapeutics (HALO) - Total assets

Total assets on the balance sheet as of September 2024 : C$2.95 Billion

According to Halozyme Therapeutics's latest financial reports the company's total assets are C$2.95 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Halozyme Therapeutics - Total assets on balance sheet (from 2002 to 2024)

Total assets by year

Year Total assets Change
2023-12-31C$2.29 B-8%
2022-12-31C$2.49 B77.53%
2021-12-31C$1.40 B90.35%
2020-12-31C$0.73 B0.05%
2019-12-31C$0.73 B23.24%
2018-12-31C$0.59 B-8.26%
2017-12-31C$0.65 B86.01%
2016-12-31C$0.35 B39.36%
2015-12-31C$0.25 B30.92%
2014-12-31C$0.19 B77.76%
2013-12-31C$0.10 B-19.12%
2012-12-31C$0.13 B100.29%
2011-12-31C$66.88 M-26.74%
2010-12-31C$91.3 M12.48%
2009-12-31C$81.17 M-12.8%
2008-12-31C$93.09 M-9.8%
2007-12-31C$0.10 B92.33%
2006-12-31C$53.66 M124.73%
2005-12-31C$23.87 M21.2%
2004-12-31C$19.7 M2246.62%
2003-12-31C$0.83 M130.55%
2002-12-31C$0.36 M774.97%
2001-12-31C$0.04 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
C$0.61 B-79.04%๐Ÿ‡บ๐Ÿ‡ธ USA
C$105.55 B 3,469.68%๐Ÿ‡บ๐Ÿ‡ธ USA
C$36.73 B 1,142.29%๐Ÿ‡บ๐Ÿ‡ธ USA
C$306.41 B 10,262.27%๐Ÿ‡บ๐Ÿ‡ธ USA
C$194.19 B 6,467.19%๐Ÿ‡ซ๐Ÿ‡ท France
C$248.91 B 8,317.59%๐Ÿ‡บ๐Ÿ‡ธ USA